日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019

英国和爱尔兰医院获得性下呼吸道感染病原体的抗菌素耐药性：2008/2009 至 2018/2019 年趋势

期刊:Journal of Antimicrobial Chemotherapy
影响因子:3.6
doi:10.1093/jac/dkaf251
Reynolds, Rosy; Morrissey, Ian; Mushtaq, Shazad; Horner, Carolyne; Adkin, Rachael; Chaudhry, Aiysha; Allen, Michael; Longshaw, Christopher; Parcell, Benjamin J; Livermore, David M
微生物学
炎症/感染
发表日期：2025
文献求助 收藏

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints

2018-2021年乌克兰抗生素耐药性调查（SOAR）结果：基于CLSI、EUCAST（剂量特异性）和药代动力学/药效学（PK/PD）断点的数据

期刊:Journal of Antimicrobial Chemotherapy
影响因子:3.6
doi:10.1093/jac/dkaf287
Torumkuney, Didem; Bratus, Elena; Yuvko, Olena; Pertseva, Tetyana; Morrissey, Ian; Beltrame, Cristiana Ossaille; Manoharan, Anand
发表日期：2025
文献求助 收藏

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Türkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints

2018-2021年土耳其抗生素耐药性调查（SOAR）结果：基于CLSI、EUCAST（剂量特异性）和药代动力学/药效学（PK/PD）断点的数据

期刊:Journal of Antimicrobial Chemotherapy
影响因子:3.6
doi:10.1093/jac/dkaf289
Torumkuney, Didem; Keles, Nergis; Hasdemir, Ufuk; Hazırolan, Gülşen; Aydemir, Sohret; Aktas, Zerrin; Oncul, Oral; Morrissey, Ian; Manoharan, Anand
发表日期：2025
文献求助 收藏

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

头孢地洛对欧洲铜绿假单胞菌和不动杆菌属（包括对美罗培南和近期β-内酰胺类/β-内酰胺酶抑制剂组合耐药的分离株）的体外活性

期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.03836-23
Santerre Henriksen, Anne; Jeannot, Katy; Oliver, Antonio; Perry, John D; Pletz, Mathias W; Stefani, Stefania; Morrissey, Ian; Longshaw, Christopher
发表日期：2024
文献求助 收藏

In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations

头孢地洛对欧洲肠杆菌科细菌（包括对美罗培南和近期β-内酰胺类/β-内酰胺酶抑制剂组合耐药的分离株）的体外活性

期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.04181-23
Santerre Henriksen, Anne; Arena, Fabio; Attwood, Marie; Canton, Rafael; Gatermann, Sören; Naas, Thierry; Morrissey, Ian; Longshaw, Christopher
微生物学
发表日期：2024
文献求助 收藏

In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China.

来自中国多中心研究的伊沙康唑及对照药物对临床分离霉菌的体外活性

期刊:Infection and Drug Resistance
影响因子:2.9
doi:10.2147/IDR.S360191
Jing Ran, Morrissey Ian, Xiao Meng, Sun Tian-Shu, Zhang Ge, Kang Wei, Guo Da-Wen, Aram Jalal A, Wang Jeffrey, Utt Eric A, Wang Yao, Xu Ying-Chun
心血管
发表日期：2022
文献求助 收藏

Sigmoid E(max) Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime

采用 Sigmoid E(max) 模型确定恩美他唑巴坦与头孢吡肟联合用药进行 MIC 测试的固定浓度

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00926-21
Knechtle, Philipp; Shapiro, Stuart; Morrissey, Ian; De Piano, Cyntia; Belley, Adam
发表日期：2021
文献求助 收藏

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017

2013年至2017年全球临床实验室分离的革兰氏阳性菌体外Eravacycline活性

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01715-19
Morrissey, Ian; Hawser, Stephen; Lob, Sibylle H; Karlowsky, James A; Bassetti, Matteo; Corey, G Ralph; Olesky, Melanie; Newman, Joseph; Fyfe, Corey
发表日期：2020
文献求助 收藏

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

2013年至2017年全球临床实验室分离的革兰氏阴性杆菌体外Eravacycline活性

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.01699-19
Morrissey, Ian; Olesky, Melanie; Hawser, Stephen; Lob, Sibylle H; Karlowsky, James A; Corey, G Ralph; Bassetti, Matteo; Fyfe, Corey
发表日期：2020
文献求助 收藏

915. Global 2018 Surveillance of Eravacycline Against Gram-positive Pathogens, Including Resistant Isolates

915. 2018 年全球对依拉环素治疗革兰氏阳性病原体（包括耐药分离株）的监测

期刊:
影响因子:
doi:10.1016/j.jhsg.2022.08.013
Peimer, Clayton A; Hurley, David; Latch, Tina; Scott, Susan; Pess, Gary M; Morgan, Steven; Hwang, Sara; Efimova, Ekaterina; Hawser, Stephen; Morrissey, Ian; Lijfrock, Virgil
微生物学
发表日期：2020
文献求助 收藏